Ascendia Pharmaceutical Solutions will participate in the 23rd Annual Contract Pharma Conference taking place September 18–19, 2025, in New Brunswick, New Jersey. The conference is a leading gathering for pharmaceutical outsourcing professionals and brings together contract development and manufacturing organizations with drug sponsors seeking development and manufacturing partners.
Ascendia Pharmaceutical Solutions specializes in solving bioavailability, solubility, and stability challenges for poorly water-soluble drug molecules. The company offers formulation development services across oral, injectable, and topical dosage forms. With capabilities in nanoemulsion, amorphous solid dispersion, and nanoparticle technologies, Ascendia Pharmaceutical Solutions provides customized solutions to advance compounds from preclinical development through commercial manufacturing.
As a fully integrated CDMO, Ascendia Pharmaceutical Solutions supports pharmaceutical and biotech companies with development, clinical trial manufacturing, and commercial production. The company’s facilities are equipped for cGMP manufacturing and analytical testing, ensuring quality and regulatory compliance. Ascendia Pharmaceutical Solutions combines advanced formulation expertise with flexible manufacturing capabilities to accelerate timelines for complex drug products.
The Contract Pharma Conference offers opportunities for drug sponsors to evaluate strategic CDMO partners. Attendees can meet with Ascendia Pharmaceutical Solutions to learn more about its technical expertise, manufacturing capabilities, and track record of success in advancing challenging drug candidates.
Drug sponsors seeking a CDMO partner with expertise in enhancing bioavailability, solubility, and stability are encouraged to connect with Ascendia Pharmaceutical Solutions during the Contract Pharma Conference. To schedule a meeting in advance, contact Ascendia Pharmaceutical Solutions today.